List of Publications (2011-Current)
2024
Cha, Jieun; Ryu, Juhee; Rawal, Diwas; Lee, Wook-Joo; Shim, Won-Sik
Antipruritic effect of ursolic acid through MRGPRX2/MrgprB2-dependent inhibition of mast cell degranulation and reduced TSLP production Journal Article
In: European Journal of Pharmacology, vol. 981, 2024, ISSN: 0014-2999.
Links | BibTeX | Tags: Mast cell, MrgprB2, MRGPRX2, TSLP, Ursolic acid
@article{Cha2024,
title = {Antipruritic effect of ursolic acid through MRGPRX2/MrgprB2-dependent inhibition of mast cell degranulation and reduced TSLP production},
author = {Jieun Cha and Juhee Ryu and Diwas Rawal and Wook-Joo Lee and Won-Sik Shim},
doi = {10.1016/j.ejphar.2024.176896},
issn = {0014-2999},
year = {2024},
date = {2024-10-00},
urldate = {2024-10-00},
journal = {European Journal of Pharmacology},
volume = {981},
publisher = {Elsevier BV},
keywords = {Mast cell, MrgprB2, MRGPRX2, TSLP, Ursolic acid},
pubstate = {published},
tppubtype = {article}
}
Shim, Nisha Adhikari Wook-Joo Lee Soojun Park Sanghee Kim Won-Sik
A phytosphingosine derivative mYG-II-6 inhibits histamine-mediated TRPV1 activation and MRGPRX2-dependent mast cell degranulation Journal Article
In: International Immunopharmacology, vol. 133, 2024, ISSN: 1567-5769.
Links | BibTeX | Tags: Histamine, Mast cell, MRGPRX2, TRPV1
@article{Adhikari2024,
title = {A phytosphingosine derivative mYG-II-6 inhibits histamine-mediated TRPV1 activation and MRGPRX2-dependent mast cell degranulation},
author = {Nisha Adhikari
Wook-Joo Lee
Soojun Park
Sanghee Kim
Won-Sik Shim},
doi = {10.1016/j.intimp.2024.112113},
issn = {1567-5769},
year = {2024},
date = {2024-05-00},
urldate = {2024-05-00},
journal = {International Immunopharmacology},
volume = {133},
publisher = {Elsevier BV},
keywords = {Histamine, Mast cell, MRGPRX2, TRPV1},
pubstate = {published},
tppubtype = {article}
}
2022
Adhikari, Nisha; Shim, Won-Sik
Caffeic acid phenethyl ester inhibits pseudo-allergic reactions via inhibition of MRGPRX2/MrgprB2-dependent mast cell degranulation Journal Article
In: Arch. Pharm. Res., vol. 45, no. 9, pp. 644–657, 2022, ISSN: 1976-3786.
Abstract | Links | BibTeX | Tags: Allergy, Calcium imaging, Mast cell, MrgprB2, MRGPRX2
@article{Adhikari2022,
title = {Caffeic acid phenethyl ester inhibits pseudo-allergic reactions via inhibition of MRGPRX2/MrgprB2-dependent mast cell degranulation},
author = {Nisha Adhikari and Won-Sik Shim},
doi = {10.1007/s12272-022-01405-2},
issn = {1976-3786},
year = {2022},
date = {2022-09-00},
urldate = {2022-09-00},
journal = {Arch. Pharm. Res.},
volume = {45},
number = {9},
pages = {644--657},
publisher = {Springer Science and Business Media LLC},
abstract = {Mast cells play essential role in allergic reactions through the process called mast cell degranulation. Recent studies have found that a basic secretagogue compound 48/80 (C48/80) induces non-IgE-mediated mast cell degranulation via activation of human Mas-related G protein-coupled receptor X2 (MRGPRX2) and mouse MrgprB2. Although previous studies have revealed that caffeic acid (CA) and its derivatives possess anti-allergic effects via IgE-dependent manner, it is largely elusive whether these compounds have impact on MRGPRX2/MrgprB2 to exert inhibitory effects. Therefore, the present study investigated whether CA as well as its derivatives - rosmarinic acid (RA) and caffeic acid phenethyl ester (CAPE) - has the ability to inhibit the activity of MRGPRX2/MrgprB2 to evoke pseudo-allergic effects. As a result, it was found that CAPE inhibits C48/80-induced activation of MRGPRX2/MrgprB2, but neither CA nor RA showed discernible inhibition. Furthermore, the β-hexosaminidase release assay showed that CAPE inhibits mouse peritoneal mast cell degranulation in both IgE-dependent and MrgprB2-dependent manners. Additionally, mouse paw edema induced by C48/80 was dramatically suppressed by co-treatment of CAPE, suggesting that CAPE possesses a protective effect on C48/80-evoked pseudo-allergic reactions. The pretreatment of CAPE also significantly decreased scratching bouts of mice evoked by C48/80, demonstrating that CAPE also has an anti-pruritic effect. Therefore, these data implicate that CAPE can suppress pseudo-allergic reactions evoked by C48/80 via MrgprB2-dependent manner. Finally, molecular docking analysis showed that CAPE is predicted to bind to human MRGPRX2 in the region where C48/80 also binds, implying that CAPE can be a competitive inhibitor of MRGPRX2. In conclusion, it is found that CAPE has the ability to inhibit MRGPRX2/MrgprB2, leading to the prevention of mast cell degranulation and further to the alleviation of mast cell reactions. These results indicate that CAPE as a CA derivative could be developed as a new protective agent that exerts dual inhibition of mast cell degranulation mediated by IgE and MRGPRX2/MrgprB2.},
keywords = {Allergy, Calcium imaging, Mast cell, MrgprB2, MRGPRX2},
pubstate = {published},
tppubtype = {article}
}
